Vergleich

KIR3DP1 Antibody (N-term) Blocking peptide

ArtNr ABC-BP5569a
Hersteller Abcepta
Menge 500 ug
Kategorie
Typ Peptides
Format Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Similar products KIR3DP1, CD158c, KIR2DS6, KIR48, KIRX, Putative killer cell immunoglobulin-like receptor like protein KIR3DP1, CD158C
Lieferbar
Primary Accession
A8MWS1
Bio Background
Killer cell immunoglobulin-like receptors (KIRs) aretransmembrane glycoproteins expressed by natural killer cells andsubsets of T cells. The KIR genes are polymorphic and highlyhomologous and they are found in a cluster on chromosome 19q13.4within the 1 Mb leukocyte receptor complex (LRC). The gene contentof the KIR gene cluster varies among haplotypes, although several'framework' genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number ofextracellular immunoglobulin domains (2D or 3D) and by whether theyhave a long (L) or short (S) cytoplasmic domain. KIR proteins withthe long cytoplasmic domain transduce inhibitory signals uponligand binding via an immune tyrosine-based inhibitory motif(ITIM), while KIR proteins with the short cytoplasmic domain lackthe ITIM motif and instead associate with the TYRO protein tyrosinekinase binding protein to transduce activating signals. The ligandsfor several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role inregulation of the immune response. This gene is one of the'framework' loci that is present on all haplotypes. This locusrepresents an alternate copy of KIR3DP1 that is represented in asmall percentage of the population and may encode a functionalprotein. The other copy is considered to be a pseudogene. [providedby RefSeq].
Bio References
Levinson, R.D., et al. Hum. Immunol. 69(6):349-353(2008)Dou, L.P., et al. Int. J. Hematol. 87(4):422-433(2008)Pavlova, Y., et al. Int. J. Immunogenet. 35(1):57-61(2008)Gomez-Lozano, N., et al. Eur. J. Immunol. 35(1):16-24(2005)Martin, A.M., et al. Gene 335, 121-131 (2004) :
Subtitle
Synthetic peptide
Other Accession
NP_001015070.1

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 500 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen